By Tess Stynes
Waters Corp. (WAT) appointed Medtronic PLC (MDT) executive
Christopher J. O'Connell as its new chief executive starting in
September.
He succeeds longtime CEO Douglas A. Berthiaume, whose plans to
retire from the role were announced nearly two years ago.
A 21-year-veteran of medical-device maker Medtronic, Mr.
O'Connell most recently served as president of its restorative
therapies group. Separately, Medtronic said Geoff Martha will
succeed Mr. O'Connell as head of the restorative therapies
group.
In August of 2013, Waters announced that Mr. Berthiaume planned
to retire as CEO within 24 months. Mr. Berthiaume was appointed
president and CEO in 1994 when the business was separated from
Millipore Corp., and assumed the additional role of chairman in
1996. He will remain the company's chairman.
Mr. Martha joined Medtronic in 2011 and currently serves as
senior vice president of corporate strategy and business
development, global communications and Medtronic Philanthropy. He
also serves as the chief integration officer for the Covidien
integration.
Write to Tess Stynes at tess.stynes@wsj.com
Access Investor Kit for Waters Corp.
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=US9418481035
Subscribe to WSJ: http://online.wsj.com?mod=djnwires